Enzyme Predicts Survival and Recurrence of Nasopharyngeal Cancer
An enzyme that can be used to predict the survival and recurrence rates for nasopharyngeal cancer have been isolated by Mayo Clinic Cancer Center scientists and collaborating Chinese researchers.
SULF2, a recently identified heparin-degrading endosulfatase, appears to be significantly overexpressed in nasopharyngeal cancers, providing hope of the eventual ability to predict recurrence and subsequent prognosis after radiation therapy, the standard treatment for nasopharyngeal cancer.
Squamous cell carcinoma of the nasopharynx or nasopharyngeal cancer is a common cancer affecting people from Southeast Asia. I
In this particular study (results presented at the American Association for Cancer Research annual meeting) found that rates of early recurrence (within five years) were significantly higher for individuals with high levels of SULF2 in their tumor.
The researchers believe that SULF2 can be used to help them explore the possibilities of treating this particular cancer.
Find more details from the full report.
Tags: Mayo-Clinic-Cancer-Center, nasopharyngeal-cancer, SUlF2-enzymeRelated Stories
POSTED IN: on cancer diagnostics, on nasopharyngeal cancer
1 opinion for Enzyme Predicts Survival and Recurrence of Nasopharyngeal Cancer
Ovarian Cancer Research
Apr 27, 2007 at 7:55 pm
Certain families may have a history of ovarian cancer. Those with a family history of ovarian cancer are at an increased risk of developing it themselves. While you can’t completely do away with the risk of ovarian cancer through diet and exercise you will be able to significantly reduce the risk of ovarian cancer as well as all other types of cancer. Staying healthy and watching your weight is an important personal strategy to help your body stay healthy and avoid all types of cancer and diseases.
-Jeanette
Have an opinion? Leave a comment: